Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas

Cell Growth and Differentiation

Volumn 8, Issue 10, 1997, Pages 1071-1082

  Sundaresan, Alamelu ^a   Claypool, Kent ^a   Mehta, Kapil ^a   Lopez Berestein, Gabriel ^a   Cabanillas, Fernando ^a   Ford Jr , Richard J ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER GROWTH; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; DOSE RESPONSE; DRUG EFFECT; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BENZOATES; BLOTTING, WESTERN; CELL DIVISION; CHROMANS; DOSAGE FORMS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIPOSOMES; LYMPHOMA, AIDS-RELATED; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; MICROSCOPY, ELECTRON; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, RETINOIC ACID; TRETINOIN; TUMOR CELLS, CULTURED;

ATRA;

EID: 0030816403     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Salles, G., Shipp, M. A., and Coiffier, B. Chemotherapy of non-Hodgkin's aggressive lymphomas. Semin. Hematol., 31: 46-69, 1994.
2. Warrell, R. P. Applications for retinoids in cancer therapy. Semin. Hematol., 31: 1-13, 1994.
3. Blomhoff, H. K., Smeland, E. B., Erikstein, B., Rasmussen, A. M., Skrede, B., Skjonsberg, C., and Blomhoff, R. Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells. J. Biol. Chem., 267: 23988-23992, 1992.
4. Chambon, P. The retinoid signaling pathway: molecular and genetic analyses. Semin. Cell Biol., 5: 115-125, 1994.
5. Pemrick, S. M., Lucas, D. A., and Grippo, J. F. The retinoid receptors. Leukemia (Baltimore), 8: S1-S10, 1994.
6. Sidell, N., Taga, T., Hirano, T., Kishimoto, T., and Saxon, A. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. J. Immunol., 146: 3809-3814, 1991.
7. Saxon, A., Keld, B., Braun, J., Dotson, A., and Sidell, N. Long-term administration of 13-cis retinoic acid in common variable immunodeficiency: circulating interleukin-6 levels, B-cell surface molecule display, and in vitro and in vivo B-cell antibody production. Immunology, 80: 477-487, 1993.
8. Felli, M. P., Vacca, A., Meco, D., Screpanti, I., Farina, A. R., Maroder, M., Martinotti, S., Petrangeli, E., Frati, L., and Gulino, A. Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. Mol. Cell. Biol., 11: 4771-4778, 1991.
9. Bruel, A., Benoit, G., De Nay, D., Brown, S., and Lanotte, M. Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells 9-cis retinoic acid induces apoptosis independent of maturation and Bcl-2 expression. Leukemia (Baltimore), 9: 1173-1184, 1995.
10. Piacentini, M., Annichiarico-Petruzzeli, M., Oliverio, S., Piredda, L., Biedler, J. L., and Melino, G. Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int. J. Cancer, 52: 271-278, 1992.
11. Afford, C. S., Pongraez, J., Stockley, R. A., Cracker, J., and Burnett, D. The induction by human interleukin-6 of apoptosis in the promonocytic cell line U937 and human neutrophils. J. Biol. Chem., 267: 21612-21616, 1992.
12. Breitman, T. R., Selonic, S. E., and Collins, S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA, 77: 2936-2940, 1980.
13. Martin, S. J., Bradley, J. G., and Cotter, T. J. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin. Exp. Immunol., 79: 448-453, 1990.
14. Oltvai, Z. N., Milliman, C. L., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
15. Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson C. B., and Korsmeyer, S. J. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death. Cell, 80: 285-291, 1995.
16. Korsmeyer, S. J. Bcl-2 a represser of lymphocyte death. Trends Immunol. Today, 13: 285-288, 1992.
17. Korsmeyer, S. J. Programmed cell death, Bcl-2. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.), Important Advances in Oncology, pp. 19-28. Philadelphia, PA: Lippincott Co., 1993.
18. Mehta, K., Sadeghi, T., McQueen, T., and Lopez-Berestein, G. Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans retinoic acid. Leuk. Res., 18: 587-596, 1994.
19. Lasic, D. D., and Papahadjopoulos, D. Liposomes revisited. Science (Washington DC), 3: 1275-1276, 1995.
20. Harrigan, P. R. Accumulation of doxorubicin and other lipophilic amines into large unilamellar vesicles in response to transmembrane pH gradients. Biochim. Biophys. Acta, 1149: 329-338, 1993.
21. Papahadjopoulos, D. Sterically stabilized liposomes: improvements in pharmacokinetics of antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA, 88: 11460, 1991.
22. Apfel, C., Bauer, F., Crettaz, M., Forni, L., Kaufman, F., LeMotte, P., Pirson, W., and Klaus, M. A retinoic acid receptor a antagonist selectively counteracts retinoic acid effects. Proc. Natl. Acad. Sci. USA, 89: 7129-7133, 1992.
23. Leid, M., Kastner, P., and Chambon, P. Multiplicity generates diversity in the retinoic acid signaling pathways. Trends Biochem. Sci., 17: 427-432, 1992.
24. Bollag, W., Majewski, S., and Jablonska, S. Cancer combination chemotherapy with retinoids. Experimental rationale. Leukemia (Baltimore), 8: 1453-1457, 1994.
25. Turley, J. M., Funakoshi, S., Ruscetti, F. W., Kasper, J., Murphy, W. J., Longo, D. L., and Birchenall-Roberts, M. C. Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor β. Cell Growth Differ., 6: 655-663, 1995.
26. Alles, A. J., Sulik, K. K. Retinoid acid induced spina-bifida: evidence for a pathogenic mechanism. Development (Camb.), 108: 73-81, 1990.
27. Alles, A. J., and Sulik, K. K. Retinoic acid induced limb-reduction defects: perturbation of zones of programmed cell death as a pathogenic mechanism. Teratology, 40: 163-171, 1989.
28. Morris-Kay, G. Retinoids in normal development and teratogenesis. Oxford, United Kingdom: Oxford University Press, 1992.
29. Fesus, L., Davies, P. J. A., and Piacentini, M. Apoptosis. Molecular mechanisms in programmed cell death. Eur. J. Cell Biol., 56: 170-177, 1991.
30. Cheng, A. L., Su, I., Chen, C., Tien, H., Lay, J., Chen, B., Pu, Y., Hong, R., Shen, M., Wang, C. W., and Chen, Y. Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study. J. Clin. Oncol., 12: 1185-1192, 1994.
31. Huang, M. E., Ye, Y. C., and Chen, S. R. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72: 567-572, 1988.
32. Warrell, R. P., Frankel, S. R., and Miller, W. H. Differentiation in therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med., 324: 1385-1393, 1991.
33. Hong, W. K., Lippman, S. M., and Itri, L. M. Prevention of second primary tumors with isotretinoin in squamous-cell carcinomas of the head and neck. N. Engl. J. Med., 323: 795-801, 1990.
34. Hockenberry, D., Nunez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348: 334-336, 1990.
35. Tsujimoto, Y., Cosman, J., and Croce, C. M. Involvement of the bcl-2 gene in human follicular lymphoma. Science (Washington DC), 228: 1440-1443, 1985.
36. Younes, J. J., Mayer, M. G., Arnesen, M. A., Aepeli, D. P., Okenand, M. M., and Frizzera, G. Bcl-2 and other genomic alterations in the prognosis of large cell lymphoma. N. Engl. J. Med., 320: 1047-1054, 1989.
37. Korsmeyer, S. Bcl-2 initiates a new category of oncogenes. Regulators of cell death. Blood, 80: 879-886, 1992.
38. Cleary, M. L., Smith, S. B., and Sklar, J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell, 47: 19-28, 1986.
39. Rabbits, T. H., and Boehm, T. Structural and functional chimerism results from chromosomal translocation in lymphoid tumors. Adv. Immunol., 50: 119-146, 1991.
40. Agarwal, N., and Mehta, K. Possible involvement of bcl-2 pathway in retinoid X receptor alpha induced apoptosis of HL-60 cells. Biochem. Biophys. Res. Commun., 230; 251-253, 1997.
41. White, E. Life, death, and the pursuit of apoptosis. Genes Dev., 10: 1-15, 1996.
42. Nagy, L., Thomazy, V. A., Shipley, G. L., Fesus, L., Lamph, W., Heyman, R. A., Chandraratna, R. A., and Davies, P. J. A. Activation of retinoid X receptors induces apoptosis in HL-60 lines. Mol. Cell. Biol., 15: 3540-3551, 1995.
43. Newcomer, M. E. Retinoid binding proteins: structural determinants important for function. FASEB J., 9: 229-239, 1995.
44. Agadir, A., Cornic, M., Lefebvre, P., Gourmel, B., Jerome, M., Degos, L., Fenaux, P., and Chomienne, C. All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: intracellular concentrations and biologic response relationship. J. Clin. Oncol., 13: 2517-2523, 1995.
45. Estey, E., Thall, P. F., Mehta, K., Rosenblum, M., Brewer, T., Jr., Simmons, V., Cabanillas, F., Kurzrock, R., and Lopez-Berestein, G. Alterations in tretinoin pharmacokinetics following administration of all-trans retinoic acid. Blood, 87: 3650-3654, 1996.
46. Ford, R. J., Tamayo, A., Martin, B. A., Niu, K., Claypool, K., Cabanillas, F., and Ambrus, J. L. Identification of B-cell growth factors (interleukin-14; high molecular weight-B-cell growth factors) in effusion fluids from patients with aggressive B-Cell lymphomas. Blood, 86: 283-293, 1995.
47. Belloc, F., Dumain, O., Boisseaqu, M. R., Jalloustre, C., Reiffers, J., Bernard, P., and Lancombe, F. A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells. Cytometry, 17: 59-65, 1994.
48. Uckun, F. M., Fauci, A. S., Chandan-Langlie, M., Myres, D., and Ambrus, J. L. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia. J. Clin. Invest., 84: 1595-1608, 1989.
49. Teeter, L. D., Petersen, D. D., Nebert, D. W., and Kuo, M. T. Murine mdr1, mdr2, and mdr3 gene expression: no coinduction with the cypla-1 and Nmo-1 genes in liver by 2,3,7,8-tetrachlorodibenzo-p-dioxin. DNA Cell Biol., 10: 433-441, 1991.